Lorazepam - NDC Database (Page 7)
434 records found
Start a Discussion
67296-0306 Oct 31, 1991
Lorazepam 1 mg Oral Tablet by Redpharm Drug Inc.
67296-0726 May 18, 2010
Lorazepam 0.5 mg Oral Tablet by Redpharm Inc.
67296-1228 Oct 01, 2007
Lorazepam 1 mg Oral Tablet by Redpharm Drug, Inc.
67296-1277 Oct 01, 2007
Lorazepam .5 mg Oral Tablet by Redpharm Drug, Inc.
67296-1332 Oct 01, 2007
Lorazepam 1 mg Oral Tablet by Redpharm Drug, Inc.
67296-1622 Jan 01, 2018
Lorazepam 1 mg Oral Tablet by Redpharm Drug, Inc.
67296-1629 Jan 01, 2019
Lorazepam .5 mg Oral Tablet by Redpharm Drug, Inc.
68071-3096 Oct 01, 2007
Lorazepam .5 mg Oral Tablet by Nucare Pharmaceuticals, Inc.
68071-3121 Oct 01, 2007
Lorazepam .5 mg Oral Tablet by Nucare Pharmaceuticals, Inc.
68071-3227 Oct 01, 2007
Lorazepam 1 mg Oral Tablet by Nucare Pharmaceuticals, Inc.
68071-3242 Oct 01, 2007
Lorazepam 1 mg Oral Tablet by Nucare Pharmaceuticals, Inc.
68071-5048 Oct 31, 1991
Lorazepam 1 mg Oral Tablet by Nucare Pharmaceuticals, Inc.
68071-5061 Oct 31, 1991
Lorazepam 1 mg Oral Tablet by Nucare Pharmaceuticals, Inc.
68071-5084 Oct 31, 1991
Lorazepam .5 mg Oral Tablet by Nucare Pharmaceuticals, Inc.
68788-0241 Aug 27, 2013
Lorazepam 1 mg Oral Tablet by Preferred Pharmaceuticals, Inc.
68788-7480 Mar 02, 2020
Lorazepam .5 mg Oral Tablet by Preferred Pharmaceuticals, Inc.
68788-9511 Feb 05, 2014
Lorazepam 1 mg/1 Oral Tablet by Preferred Pharmaceuticals, Inc.
68788-9839 Mar 29, 2012
Lorazepam 1 mg Oral Tablet by Preferred Pharmaceuticals, Inc
68788-9840 Mar 29, 2012
Lorazepam 0.5 mg Oral Tablet by Preferred Pharmaceuticals, Inc
69315-904 May 16, 2023
Lorazepam .5 mg Oral Tablet by Leading Pharma, LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us .
